Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19-Reference-Cited by-同舟云学术

Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19

Published:2022-06-30 Issue:1 Volume:384 Page:109-115
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Gambardella Jessica,Kansakar Urna^ORCID,Sardu Celestino,Messina Vincenzo,Jankauskas Stanislovas S.,Marfella Raffaele,Maggi Paolo,Wang Xujun,Mone Pasquale,Paolisso Giuseppe,Sorriento Daniela,Santulli Gaetano^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference100 articles.

1. l-Arginine and COVID-19: an update;Adebayo;Nutrients,2021

2. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways;Amini-Farsani;Int Immunopharmacol,2021

3. Antoniou KM Vasarmidi E Russell AM Andrejak C Crestani B Delcroix M Dinh-Xuan AT Poletti V Sverzellati N Vitacca M , (2022) European respiratory society statement on long COVID-19 follow-up. Eur Respir J DOI: 10.1183/13993003.02174-2021 [published ahead of print].

4. Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study

5. MicroRNA-mediated regulation of the virus cycle and pathogenesis in the SARS-CoV-2 disease;Battaglia;Int J Mol Sci,2021

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between microRNAs and COVID-19 complications;Non-coding RNA Research;2025-02

2. Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19;Thrombosis Journal;2024-09-05

3. Circulating miRNAs in the Plasma of Post-COVID-19 Patients with Typical Recovery and Those with Long-COVID Symptoms: Regulation of Immune Response-Associated Pathways;Non-Coding RNA;2024-09-02

4. Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases;IJC Heart & Vasculature;2024-08

5. Exosomes, and the potential for exosome‐based interventions against COVID‐19;Reviews in Medical Virology;2024-06-25